Catalyst OrthoScience
Evaluation of the performance and safety of the Catalyst CSR Shoulder System with clinical and radiographic results at multiple time points through 24 months postoperatively This study will be a prospective multi-center study conducted in the United States.
Osteoarthritis Shoulder
Avascular Necrosis of the Head of Humerus
Rheumatoid Arthritis Shoulder
Catalyst CSR Total Shoulder System
NA
The purpose of this study is to assess the performance and safety of the Catalyst CSR Shoulder System in skeletally mature patients with degenerative disease of the glenohumeral joint where hemi or total shoulder arthroplasty is determined by the surgeon to be the preferred method of treatment. Patients who sign informed consent and meet the inclusion/exclusion criteria will have the Catalyst CSR Shoulder system implanted at participating sites. Data will be collected at baseline (pre-operative), perioperatively, and postoperatively at 3 months, 6 months, 12 months and 24 months. This study is expected to take 36 months to complete.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 90 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | Analysis of the Performance and Safety of the Catalyst CSR Shoulder System - A Prospective Study |
Actual Study Start Date : | 2022-07-22 |
Estimated Primary Completion Date : | 2026-02-28 |
Estimated Study Completion Date : | 2026-02-28 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Beaumont Hospital Royal Oak
Royal Oak, Michigan, United States, 48073
RECRUITING
Kaiser Permanente Northwest Center for Health Research
Portland, Oregon, United States, 97227
RECRUITING
Lifespan/University Orthopedics
Providence, Rhode Island, United States, 02914